North America Radiopharmaceutical Market by Manufacturers, Countries, Type and Application, Forecast to 2022
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Scope of the Report:
This report focuses on the Radiopharmaceutical in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Radiopharmaceutical Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Radiopharmaceutical, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Radiopharmaceutical, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Radiopharmaceutical market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Radiopharmaceutical Research Findings and Conclusion, Appendix, methodology and data source
Scope of the Report:
This report focuses on the Radiopharmaceutical in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- Bayer
- Triad Isotopes
- Lantheus
- GE Healthcare
- Mallinckrodt
- Eli Lilly
- Bracco Imaging
- SIEMENS
- Navidea
- Nordion
- IBA Group
- Jubilant Pharma
- United States
- Canada
- Mexico
- SPECT Radioisotopes
- PET Radioisotopes
- Other Diagnostic Radioisotopes
- Therapeutic Radioisotopes
- Oncology
- Cardiology
- Other
Chapter 1, to describe Radiopharmaceutical Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Radiopharmaceutical, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Radiopharmaceutical, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Radiopharmaceutical market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Radiopharmaceutical Research Findings and Conclusion, Appendix, methodology and data source
1 MARKET OVERVIEW
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 SPECT Radioisotopes
1.2.2 PET Radioisotopes
1.2.3 Other Diagnostic Radioisotopes
1.2.4 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Profile
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Bayer News
2.2 Triad Isotopes
2.2.1 Profile
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Triad Isotopes News
2.3 Lantheus
2.3.1 Profile
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Lantheus News
2.4 GE Healthcare
2.4.1 Profile
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 GE Healthcare News
2.5 Mallinckrodt
2.5.1 Profile
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Mallinckrodt News
2.6 Eli Lilly
2.6.1 Profile
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Eli Lilly News
2.7 Bracco Imaging
2.7.1 Profile
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Bracco Imaging News
2.8 SIEMENS
2.8.1 Profile
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 SIEMENS News
2.9 Navidea
2.9.1 Profile
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Navidea News
2.10 Nordion
2.10.1 Profile
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Nordion News
2.11 IBA Group
2.11.1 Profile
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 IBA Group News
2.12 Jubilant Pharma
2.12.1 Profile
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Jubilant Pharma News
3 NORTH AMERICA RADIOPHARMACEUTICAL MARKET COMPETITION, BY MANUFACTURER
3.1 North America Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Radiopharmaceutical Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA RADIOPHARMACEUTICAL MARKET ANALYSIS BY COUNTRIES
4.1 North America Radiopharmaceutical Sales Market Share by Countries
4.2 North America Radiopharmaceutical Sales by Countries (2012-2017)
4.3 North America Radiopharmaceutical Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION RADIOPHARMACEUTICAL BY TYPE
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Radiopharmaceutical Sales and Market Share by Type (2012-2017)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
5.2 SPECT Radioisotopes Sales Growth and Price
5.2.1 North America SPECT Radioisotopes Sales Growth (2012-2017)
5.2.2 North America SPECT Radioisotopes Price (2012-2017)
5.3 PET Radioisotopes Sales Growth and Price
5.3.1 North America PET Radioisotopes Sales Growth (2012-2017)
5.3.2 North America PET Radioisotopes Price (2012-2017)
5.4 Other Diagnostic Radioisotopes Sales Growth and Price
5.4.1 North America Other Diagnostic Radioisotopes Sales Growth (2012-2017)
5.4.2 North America Other Diagnostic Radioisotopes Price (2012-2017)
5.5 Therapeutic Radioisotopes Sales Growth and Price
5.5.1 North America Therapeutic Radioisotopes Sales Growth (2012-2017)
5.5.2 North America Therapeutic Radioisotopes Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION RADIOPHARMACEUTICAL BY APPLICATION
6.1 North America Radiopharmaceutical Sales Market Share by Application (2012-2017)
6.2 Oncology Sales Growth (2012-2017)
6.3 Cardiology Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)
7 UNITED STATES RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Radiopharmaceutical Sales and Market Share by Type
7.3 United States Radiopharmaceutical Sales by Application (2012-2017)
7.4 United States Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Radiopharmaceutical Sales and Market Share by Manufacturer
7.4.2 United States Radiopharmaceutical Revenue and Market Share by Manufacturer
7.5 United States Radiopharmaceutical Export and Import (2012-2017)
8 CANADA RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Radiopharmaceutical Sales and Market Share by Type
8.3 Canada Radiopharmaceutical Sales by Application (2012-2017)
8.4 Canada Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Radiopharmaceutical Sales and Market Share by Manufacturer
8.4.2 Canada Radiopharmaceutical Revenue and Market Share by Manufacturer
8.5 Canada Radiopharmaceutical Export and Import (2012-2017)
9 MEXICO RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Radiopharmaceutical Sales and Market Share by Type
9.3 Mexico Radiopharmaceutical Sales by Application (2012-2017)
9.4 Mexico Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Radiopharmaceutical Sales and Market Share by Manufacturer
9.4.2 Mexico Radiopharmaceutical Revenue and Market Share by Manufacturer
9.5 Mexico Radiopharmaceutical Export and Import (2012-2017)
10 RADIOPHARMACEUTICAL MARKET FORECAST (2017-2022)
10.1 North America Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
10.2 Radiopharmaceutical Market Forecast by Countries (2017-2022)
10.2.1 United States Radiopharmaceutical Forecast (2017-2022)
10.2.2 Canada Radiopharmaceutical Forecast (2017-2022)
10.2.3 Mexico Radiopharmaceutical Forecast (2017-2022)
10.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
10.4 Radiopharmaceutical Market Forecast by Application (2017-2022)
11 RADIOPHARMACEUTICAL MANUFACTURING COST ANALYSIS
11.1 Radiopharmaceutical Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Radiopharmaceutical
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Radiopharmaceutical Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 SPECT Radioisotopes
1.2.2 PET Radioisotopes
1.2.3 Other Diagnostic Radioisotopes
1.2.4 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Profile
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Bayer News
2.2 Triad Isotopes
2.2.1 Profile
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Triad Isotopes News
2.3 Lantheus
2.3.1 Profile
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Lantheus News
2.4 GE Healthcare
2.4.1 Profile
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 GE Healthcare News
2.5 Mallinckrodt
2.5.1 Profile
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Mallinckrodt News
2.6 Eli Lilly
2.6.1 Profile
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Eli Lilly News
2.7 Bracco Imaging
2.7.1 Profile
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Bracco Imaging News
2.8 SIEMENS
2.8.1 Profile
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 SIEMENS News
2.9 Navidea
2.9.1 Profile
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Navidea News
2.10 Nordion
2.10.1 Profile
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Nordion News
2.11 IBA Group
2.11.1 Profile
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 IBA Group News
2.12 Jubilant Pharma
2.12.1 Profile
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Jubilant Pharma News
3 NORTH AMERICA RADIOPHARMACEUTICAL MARKET COMPETITION, BY MANUFACTURER
3.1 North America Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Radiopharmaceutical Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
3.5 Market Competition Trend
4 NORTH AMERICA RADIOPHARMACEUTICAL MARKET ANALYSIS BY COUNTRIES
4.1 North America Radiopharmaceutical Sales Market Share by Countries
4.2 North America Radiopharmaceutical Sales by Countries (2012-2017)
4.3 North America Radiopharmaceutical Revenue (Value) by Countries (2012-2017)
5 NORTH AMERICA MARKET SEGMENTATION RADIOPHARMACEUTICAL BY TYPE
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Radiopharmaceutical Sales and Market Share by Type (2012-2017)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
5.2 SPECT Radioisotopes Sales Growth and Price
5.2.1 North America SPECT Radioisotopes Sales Growth (2012-2017)
5.2.2 North America SPECT Radioisotopes Price (2012-2017)
5.3 PET Radioisotopes Sales Growth and Price
5.3.1 North America PET Radioisotopes Sales Growth (2012-2017)
5.3.2 North America PET Radioisotopes Price (2012-2017)
5.4 Other Diagnostic Radioisotopes Sales Growth and Price
5.4.1 North America Other Diagnostic Radioisotopes Sales Growth (2012-2017)
5.4.2 North America Other Diagnostic Radioisotopes Price (2012-2017)
5.5 Therapeutic Radioisotopes Sales Growth and Price
5.5.1 North America Therapeutic Radioisotopes Sales Growth (2012-2017)
5.5.2 North America Therapeutic Radioisotopes Price (2012-2017)
6 NORTH AMERICA MARKET SEGMENTATION RADIOPHARMACEUTICAL BY APPLICATION
6.1 North America Radiopharmaceutical Sales Market Share by Application (2012-2017)
6.2 Oncology Sales Growth (2012-2017)
6.3 Cardiology Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)
7 UNITED STATES RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Radiopharmaceutical Sales and Market Share by Type
7.3 United States Radiopharmaceutical Sales by Application (2012-2017)
7.4 United States Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Radiopharmaceutical Sales and Market Share by Manufacturer
7.4.2 United States Radiopharmaceutical Revenue and Market Share by Manufacturer
7.5 United States Radiopharmaceutical Export and Import (2012-2017)
8 CANADA RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 Canada Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Radiopharmaceutical Sales and Market Share by Type
8.3 Canada Radiopharmaceutical Sales by Application (2012-2017)
8.4 Canada Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Radiopharmaceutical Sales and Market Share by Manufacturer
8.4.2 Canada Radiopharmaceutical Revenue and Market Share by Manufacturer
8.5 Canada Radiopharmaceutical Export and Import (2012-2017)
9 MEXICO RADIOPHARMACEUTICAL SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Mexico Radiopharmaceutical Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Radiopharmaceutical Sales and Market Share by Type
9.3 Mexico Radiopharmaceutical Sales by Application (2012-2017)
9.4 Mexico Radiopharmaceutical Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Radiopharmaceutical Sales and Market Share by Manufacturer
9.4.2 Mexico Radiopharmaceutical Revenue and Market Share by Manufacturer
9.5 Mexico Radiopharmaceutical Export and Import (2012-2017)
10 RADIOPHARMACEUTICAL MARKET FORECAST (2017-2022)
10.1 North America Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
10.2 Radiopharmaceutical Market Forecast by Countries (2017-2022)
10.2.1 United States Radiopharmaceutical Forecast (2017-2022)
10.2.2 Canada Radiopharmaceutical Forecast (2017-2022)
10.2.3 Mexico Radiopharmaceutical Forecast (2017-2022)
10.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
10.4 Radiopharmaceutical Market Forecast by Application (2017-2022)
11 RADIOPHARMACEUTICAL MANUFACTURING COST ANALYSIS
11.1 Radiopharmaceutical Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Radiopharmaceutical
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 Radiopharmaceutical Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2016
12.4 Downstream Buyers
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
LIST OF TABLES AND FIGURES
Figur
Figure Radiopharmaceutical Picture
Table Product Specifications of Radiopharmaceutical
Figure North America Sales Market Share of Radiopharmaceutical by Types in 2016
Table Types of Radi
Figur
Figure Radiopharmaceutical Picture
Table Product Specifications of Radiopharmaceutical
Figure North America Sales Market Share of Radiopharmaceutical by Types in 2016
Table Types of Radi
